• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 2.00% Nasdaq Up 1.66%

    DepoMed Inc. (DEPO)

    -NasdaqGS
    16.07 0.00(0.00%) Feb 12, 4:00PM EST
    Prev Close:16.07
    Open:16.40
    Bid:15.00 x 500
    Ask:16.24 x 100
    1y Target Est:26.67
    Beta:1.67348
    Earnings Date:Feb 22 - Feb 26 (Est.)
    Day's Range:15.19 - 16.40
    52wk Range:13.27 - 33.74
    Volume:1,789,929
    Avg Vol (3m):1,753,170
    Market Cap:971.94M
    P/E (ttm):19.65
    EPS (ttm):0.82
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    DEPO 0.00%971.94M
    PFEUp 0.79%181.25B
    MRKUp 0.37%136.97B

    Key Statistics

    Forward P/E (1 yr):9.68
    P/S (ttm):2.28
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :0.80
    Quarterly EPS Est (Dec-15) :0.29
    Mean Recommendation*:2.2
    PEG Ratio (5 yr expected):0.67

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Depomed, Inc., a specialty pharmaceutical company, develops products for pain and other central nervous system conditions in the United States. It offers Gralise (gabapentin), an once-daily product for the management of postherpetic neuralgia; CAM... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback